Margaret Wecker

500 total citations
9 papers, 364 citations indexed

About

Margaret Wecker is a scholar working on Pharmacology, Molecular Biology and Virology. According to data from OpenAlex, Margaret Wecker has authored 9 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Virology. Recurrent topics in Margaret Wecker's work include HIV Research and Treatment (3 papers), vaccines and immunoinformatics approaches (2 papers) and Respiratory viral infections research (2 papers). Margaret Wecker is often cited by papers focused on HIV Research and Treatment (3 papers), vaccines and immunoinformatics approaches (2 papers) and Respiratory viral infections research (2 papers). Margaret Wecker collaborates with scholars based in United States, Botswana and South Africa. Margaret Wecker's co-authors include Frederick G. Hayden, Ronald B. Turner, Gerhardt Pohl, Theodore J. Witek, Birgit Winther, Eugene McNally, Jay Grossman, Nina D. Russell, Catherine L. Wood and Mark J. Newman and has published in prestigious journals such as JAMA, Journal of Allergy and Clinical Immunology and Journal of Pharmaceutical Sciences.

In The Last Decade

Margaret Wecker

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Wecker United States 7 119 101 90 89 87 9 364
A Wegmann Switzerland 9 85 0.7× 37 0.4× 50 0.6× 72 0.8× 30 0.3× 38 330
A Goolam Mahomed South Africa 12 243 2.0× 58 0.6× 62 0.7× 133 1.5× 145 1.7× 17 577
Sae J. Hahm United States 6 235 2.0× 41 0.4× 45 0.5× 83 0.9× 70 0.8× 7 566
Katja Finsterbusch United Kingdom 10 81 0.7× 22 0.2× 184 2.0× 183 2.1× 49 0.6× 14 492
Mongkol Lao‐Araya Thailand 11 92 0.8× 146 1.4× 34 0.4× 33 0.4× 12 0.1× 30 380
Esi Lamousé‐Smith United States 9 60 0.5× 31 0.3× 124 1.4× 191 2.1× 29 0.3× 18 422
R Leung Hong Kong 7 34 0.3× 143 1.4× 84 0.9× 33 0.4× 44 0.5× 10 347
Gina Racine Canada 12 130 1.1× 29 0.3× 49 0.5× 73 0.8× 136 1.6× 19 426
Hideo Togashi Japan 9 64 0.5× 114 1.1× 55 0.6× 226 2.5× 30 0.3× 13 485
J. Riethmueller Germany 12 139 1.2× 43 0.4× 53 0.6× 173 1.9× 377 4.3× 17 609

Countries citing papers authored by Margaret Wecker

Since Specialization
Citations

This map shows the geographic impact of Margaret Wecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Wecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Wecker more than expected).

Fields of papers citing papers by Margaret Wecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Wecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Wecker. The network helps show where Margaret Wecker may publish in the future.

Co-authorship network of co-authors of Margaret Wecker

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Wecker. A scholar is included among the top collaborators of Margaret Wecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Wecker. Margaret Wecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wecker, Margaret, Peter B. Gilbert, Nina D. Russell, et al.. (2012). Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype CgagVaccine in Healthy HIV-1-Uninfected Adults. Clinical and Vaccine Immunology. 19(10). 1651–1660. 50 indexed citations
2.
Jin, Xia, Mark J. Newman, Stephen C. DeRosa, et al.. (2009). A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults. Vaccine. 27(50). 7080–7086. 34 indexed citations
3.
Gorse, Geoffrey J., Lindsey R. Baden, Margaret Wecker, et al.. (2007). Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults. Vaccine. 26(2). 215–223. 50 indexed citations
4.
Turner, Ronald B., Margaret Wecker, Gerhardt Pohl, et al.. (1999). Efficacy of Tremacamra, a Soluble Intercellular Adhesion Molecule 1, for Experimental Rhinovirus Infection. JAMA. 281(19). 1797–1797. 140 indexed citations
5.
Pitkäranta, Anne, Margaret Wecker, David C. Korts, & Frederick G. Hayden. (1998). Combined Intranasal Ipratropium Bromide and Oxymetazoline in Experimental Rhinovirus Infection. American Journal of Rhinology. 12(2). 125–130. 4 indexed citations
6.
Wood, Catherine L., Philip Fireman, Jay Grossman, Margaret Wecker, & Thomas R. MacGregor. (1995). Product characteristics and pharmacokinetics of intranasal ipratropium bromide. Journal of Allergy and Clinical Immunology. 95(5). 1111–1116. 37 indexed citations
7.
Diamond, Louis S., Robert J. Dockhorn, Jay Grossman, et al.. (1995). A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. Journal of Allergy and Clinical Immunology. 95(5). 1139–1146. 34 indexed citations
8.
Graves, David A., Margaret Wecker, Lewis P. Amsel, et al.. (1988). Influence of a standard meal on the absorption of a controlled release pseudoephedrine suspension. Biopharmaceutics & Drug Disposition. 9(3). 267–272. 4 indexed citations
9.
Wecker, Margaret, David A. Graves, Lewis P. Amsel, O. N. Hinsvark, & Keith S. Rotenberg. (1987). Influence of a Standard Meal on the Absorption of Controlled-Release Pseudoephedrine Capsules. Journal of Pharmaceutical Sciences. 76(1). 29–31. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026